NCT05380635Phase 2Completed

PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma

Study sponsor: Soligenix

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-08-16Actual
Enrollment · participants9Actual
Source updated2023-06-07Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.